Unselective screening for liver disease may not be cost effectiveBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5384 (Published 03 September 2014) Cite this as: BMJ 2014;349:g5384
- Michael Marks, clinical research fellow1,
- Andrew Chadwick, registrar2
- 1Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK
- 2Intensive Care Medicine, Oxford University Hospitals NHS Trust, Oxford, UK
Sattar and colleagues review the epidemiology, manifestations, and management of non-alcoholic fatty liver disease.1 They recommend considering screening for other liver conditions such as chronic viral hepatitis, autoimmune liver disease, haemochromatosis, and drug induced liver injury. The value and cost implications of such screening in people with abnormal results in liver function tests are unclear.
A prospective …